Jain MD, Ziccheddu B, Coughlin CA, et al. Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma. Blood. 2022;140(5):491-503.

On page 491, the byline omits an author, Erin A. Dean. The byline and author affiliations should read as follows:

Michael D. Jain,^1,∗ Bachisio Ziccheddu,^2,3,∗ Caroline A. Coughlin,^4,5,∗ Rawan Faramand,¹ Anthony J. Griswold,⁶ Kayla M. Reid,¹ Meghan Menges,¹ Erin A. Dean,⁷ Yonghong Zhang,⁸ Ling Cen,⁸ Xuefeng Wang,⁸ Mohammad Hussaini,⁹ Ola Landgren,^2,3 Marco L. Davila,^1,† Jonathan H. Schatz,^2,3,† Frederick L. Locke,^1,† and Francesco Maura^2,3,†

¹Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine, Tampa, FL; ²Division of Hematology, Department of Medicine, ³Sylvester Comprehensive Cancer Center, ⁴Medical Scientist Training Program, ⁵Sheila and David Fuente Graduate Program in Cancer Biology, and ⁶John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL; ⁷Division of Hematology and Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL; and ⁸Department of Biostatistics and Bioinformatics and ⁹Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine, Tampa, FL

On page 501, the authorship contribution statement should include the information that Erin A. Dean collected data. The conflict-of-interest disclosure paragraph should include the following: “E.A.D. reports unlicensed patents (no royalties) in the field of cellular immunotherapy held by Moffitt Cancer Center.” The ORCID profile paragraph should include the following: “E.A.D., 0000-0003-3153-223X.”